I love working with cutting-edge proprietary technology, but ultimately success in a company boils down to having the right people in place to execute the business plan.”
Primary Areas of Expertise
Focus: Pharma and Biotech Companies
- CBO of private biotech companies
- Portfolio strategy development and implementation of licensing campaign
- In- and out-licensing/asset sales
- M&A advisory services
- Fundraising advisory services
From 2006 to 2014, Mike was Vice President of Corporate and Strategic Development at Scynexis, Inc., most recently as a member of the team that executed the company’s $62M IPO. From 2004 to 2006, Mike was a Managing Director of Pharmavent Partners, a European Life Sciences venture capital fund headquartered in Paris, where he was responsible for UK-based investment opportunities. From 2001 to 2004, he was Global Vice President, Ventures & Business Development for BTG plc, a FTSE-250 company with responsibility for the company’s portfolio of more than 15 investments in early stage to public companies. Prior to this Mike worked in the corporate venture group of Aventis (Paris) and in their business development group. Earlier in his career he was a patent attorney in the Rhone-Poulenc Intellectual Property department, based in France and the UK.
Mike is a British and European Patent Attorney, holds an Honors degree in Chemistry from Southampton University, UK and an Executive Certificate in General Management from the Cedep INSEAD business school, France.